{"id":"https://openalex.org/W2151969933","doi":"https://doi.org/10.1016/j.ahj.2014.05.004","title":"Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population","display_name":"Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-15","ids":{"openalex":"https://openalex.org/W2151969933","doi":"https://doi.org/10.1016/j.ahj.2014.05.004","mag":"2151969933","pmid":"https://pubmed.ncbi.nlm.nih.gov/25066560"},"language":"en","primary_location":{"id":"doi:10.1016/j.ahj.2014.05.004","doi":"https://doi.org/10.1016/j.ahj.2014.05.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ahj.2014.05.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0002870314002798/pdf","source":{"id":"https://openalex.org/S46995015","display_name":"American Heart Journal","issn_l":"0002-8703","issn":["0002-8703","1097-6744"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Heart Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2151969933"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0002870314002798/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064339118","display_name":"Michael A. Blazing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael A. Blazing","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC. Electronic address: michael.blazing@dm.duke.edu","Duke Clinical Research Institute, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC. Electronic address: michael.blazing@dm.duke.edu","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045665978","display_name":"Robert Patrick Giugliano","orcid":"https://orcid.org/0000-0003-4110-7675","observed_orcids":["https://orcid.org/0000-0003-4110-7675"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert P. Giugliano","raw_affiliation_strings":["Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026602252","display_name":"Christopher Paul Cannon","orcid":"https://orcid.org/0000-0003-4596-2791","observed_orcids":["https://orcid.org/0000-0003-4596-2791"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher P. Cannon","raw_affiliation_strings":["Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas A. Musliner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas A. Musliner","raw_affiliation_strings":["Merck & Co., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107836330","display_name":"Andrew M. Tershakovec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew M. Tershakovec","raw_affiliation_strings":["Merck & Co., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082493414","display_name":"Jennifer A. White","orcid":"https://orcid.org/0000-0002-5977-0670","observed_orcids":["https://orcid.org/0000-0002-5977-0670"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer A. White","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Craig Reist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Craig Reist","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081871633","display_name":"Amy McCagg","orcid":"https://orcid.org/0000-0002-7920-2160","observed_orcids":["https://orcid.org/0000-0002-7920-2160"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy McCagg","raw_affiliation_strings":["Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022267024","display_name":"Eugene Braunwald","orcid":"https://orcid.org/0000-0002-3472-626X","observed_orcids":["https://orcid.org/0000-0002-3472-626X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eugene Braunwald","raw_affiliation_strings":["Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombolysis in Myocardial Infarction [TIMI] Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107840885","display_name":"Robert M. Califf","orcid":"https://orcid.org/0000-0003-0231-3724","observed_orcids":["https://orcid.org/0000-0003-0231-3724"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert M. Califf","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC","institution_ids":["https://openalex.org/I4405286153"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5064339118"],"corresponding_institution_ids":["https://openalex.org/I4405286153"],"apc_list":{"value":4070,"currency":"USD","value_usd":4070},"apc_paid":{"value":4070,"currency":"USD","value_usd":4070},"fwci":14.8692,"has_fulltext":true,"cited_by_count":100,"citation_normalized_percentile":{"value":0.99402959,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"168","issue":"2","first_page":"205","last_page":"212.e1"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9769999980926514},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9810000061988831},{"id":"https://openalex.org/keywords/improve-it-trial","display_name":"IMPROVE-IT trial","score":0.9470000267028809},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.9179999828338623},{"id":"https://openalex.org/keywords/ldl-cholesterol-targets","display_name":"LDL cholesterol targets","score":0.4830000102519989},{"id":"https://openalex.org/keywords/st-elevation-myocardial-infarction","display_name":"ST-elevation myocardial infarction","score":0.8190000057220459},{"id":"https://openalex.org/keywords/unstable-angina","display_name":"unstable angina","score":0.8730000257492065},{"id":"https://openalex.org/keywords/non-st-elevation-myocardial-infarction","display_name":"non-ST-elevation myocardial infarction","score":0.9210000038146973},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9456405639648438},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9240571856498718},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.8487293124198914},{"id":"https://openalex.org/C2777785093","wikidata":"https://www.wikidata.org/wiki/Q2032041","display_name":"Unstable angina","level":3,"score":0.8252658247947693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7336253523826599},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7231069207191467},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6602200865745544},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.5821022987365723},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48512396216392517},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.45400500297546387},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4534958302974701},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4454510807991028},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ahj.2014.05.004","doi":"https://doi.org/10.1016/j.ahj.2014.05.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ahj.2014.05.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0002870314002798/pdf","source":{"id":"https://openalex.org/S46995015","display_name":"American Heart Journal","issn_l":"0002-8703","issn":["0002-8703","1097-6744"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Heart Journal","raw_type":"journal-article"},{"id":"pmid:25066560","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25066560","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American heart journal","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ahj.2014.05.004","doi":"https://doi.org/10.1016/j.ahj.2014.05.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ahj.2014.05.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0002870314002798/pdf","source":{"id":"https://openalex.org/S46995015","display_name":"American Heart Journal","issn_l":"0002-8703","issn":["0002-8703","1097-6744"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Heart Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320315666","display_name":"Medicines Company","ror":null},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2151969933.pdf","grobid_xml":"https://content.openalex.org/works/W2151969933.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W156853490","https://openalex.org/W198828404","https://openalex.org/W1430649507","https://openalex.org/W1964532888","https://openalex.org/W1977399475","https://openalex.org/W1981193135","https://openalex.org/W1989042353","https://openalex.org/W2018711158","https://openalex.org/W2019071303","https://openalex.org/W2025690892","https://openalex.org/W2040462758","https://openalex.org/W2052094004","https://openalex.org/W2100800328","https://openalex.org/W2106343349","https://openalex.org/W2111385165","https://openalex.org/W2118825330","https://openalex.org/W2120289695","https://openalex.org/W2134120087","https://openalex.org/W2139168645","https://openalex.org/W2150799450","https://openalex.org/W2159449551","https://openalex.org/W2164089346","https://openalex.org/W2164324917","https://openalex.org/W2165605025","https://openalex.org/W2167045683","https://openalex.org/W2187593761","https://openalex.org/W2305718992","https://openalex.org/W2413706018","https://openalex.org/W3021659692","https://openalex.org/W3021842026","https://openalex.org/W6906490681"],"related_works":["https://openalex.org/W2602092188","https://openalex.org/W195749522","https://openalex.org/W2201613823","https://openalex.org/W2150799450","https://openalex.org/W2141079535","https://openalex.org/W2796936639","https://openalex.org/W2251889296","https://openalex.org/W2780743843","https://openalex.org/W2027316231","https://openalex.org/W2336425791"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,54,80,108,155,176,216,250],"IMProved":[2],"Reduction":[3],"of":[4,26,33,111,165,183,224,235],"Outcomes:":[5],"Vytorin":[6],"Efficacy":[7],"International":[8],"Trial":[9],"(IMPROVE-IT)":[10],"is":[11,59,86,113,207],"evaluating":[12,208],"the":[13,24,151,173,221,230,244],"potential":[14],"benefit":[15],"for":[16,69,196,201],"reduction":[17,241],"in":[18,36],"major":[19],"cardiovascular":[20],"(CV)":[21],"events":[22,112],"from":[23,137,247],"addition":[25],"ezetimibe":[27,227],"versus":[28],"placebo":[29],"to":[30,92,104,140,168],"40":[31],"mg/d":[32],"simvastatin":[34,81],"therapy":[35],"patients":[37,119,166],"who":[38],"present":[39],"with":[40,120,172,226],"acute":[41],"coronary":[42,74],"syndromes":[43],"and":[44,73,99,146,160,186,198,228,256],"have":[45,238],"low-density":[46],"lipoprotein":[47],"cholesterol":[48],"(LDL-C)":[49],"\u2264":[50],"125":[51],"mg/dL.":[52,88],"METHODS:":[53],"primary":[55],"composite":[56],"end":[57],"point":[58],"CV":[60],"death,":[61],"nonfatal":[62,66],"myocardial":[63],"infarction":[64],"(MI),":[65],"stroke,":[67],"rehospitalization":[68],"unstable":[70],"angina":[71],"(UA),":[72],"revascularization":[75],"(\u2265":[76],"30":[77],"days":[78],"postrandomization).":[79],"monotherapy":[82],"arm's":[83],"LDL-C":[84,95,190,209,214,225,236,245],"target":[85],"<70":[87],"Ezetimibe":[89],"was":[90,158,193],"assumed":[91],"further":[93],"lower":[94],"by":[96],"15":[97],"mg/dL":[98,195,200],"produce":[100],"an":[101],"estimated":[102],"~8%":[103],"9%":[105],"treatment":[106,170],"effect.":[107],"targeted":[109,213],"number":[110],"5,250.":[114],"RESULTS:":[115],"We":[116],"enrolled":[117],"18,144":[118],"either":[121],"ST-segment":[122],"elevation":[123,131],"MI":[124,132],"(STEMI,":[125],"n":[126,134],"=":[127,135],"5,192)":[128],"or":[129],"UA/non-ST-segment":[130],"(UA/NSTEMI,":[133],"12,952)":[136],"October":[138],"2005":[139],"July":[141],"2010.":[142],"Western":[143],"Europe":[144],"(40%)":[145],"North":[147],"America":[148],"(38%)":[149],"were":[150],"leading":[152],"enrolling":[153],"regions.":[154],"STEMI":[156,197],"cohort":[157],"younger":[159],"had":[161,179],"a":[162,180,248],"higher":[163,181],"percentage":[164],"naive":[167],"lipid-lowering":[169],"compared":[171],"UA/NSTEMI":[174,177,202],"cohort.":[175],"group":[178],"prevalence":[182],"diabetes,":[184],"hypertension,":[185],"prior":[187],"MI.":[188],"Median":[189],"at":[191],"entry":[192],"100":[194],"93":[199],"patients.":[203],"CONCLUSIONS:":[204],"This":[205],"trial":[206],"lowering":[210,234,246],"beyond":[211],"previously":[212],"levels.":[215],"results":[217,251],"depend":[218],"on":[219,229],"achieving":[220],"desired":[222],"separation":[223],"assumption":[231],"that":[232],"ezetimibe's":[233],"will":[237],"similar":[239],"event":[240],"efficacy":[242],"as":[243],"statin.":[249],"could":[252],"affect":[253],"future":[254],"therapies":[255],"guidelines.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2151969933","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":42},{"year":2014,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
